Sustained low-dose treatment with the histone deacetylase inhibitor LBH589 induces terminal differentation of osteosarcoma cells

journal contribution

posted on 2013-01-01, 00:00 authored by J Cain, A McCaw, W Jayasekara, F Rossello, K Marini, A Irving, M Kansara, D Thomas, David Ashley, D Watkins

Sustained low-dose treatment with the histone deacetylase inhibitor LBH589 induces terminal differentation of osteosarcoma cells

History

Journal

Sarcoma

Pagination

1 - 11

Location

New York, N. Y.

Open access

Yes

ISSN

1357-714X

Language

eng

Publication classification

C1 Refereed article in a scholarly journal

Usage metrics

Categories

No categories selected

Keywords

cancer osteosarcoma HDACi therapy Panobinostat LBH589 terminal differentiation

Licence

All Rights Reserved

Exports